Search Results - "Shokat, K.M"
-
1
Chemically targeting the PI3K family
Published in Biochemical Society transactions (01-04-2007)“…PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metabolism and survival. The frequent activation of the PI3K pathway in cancer has…”
Get more information
Journal Article -
2
73 Differential pathway resiliency in response to MAPK inhibition in BRAF-mutant cancer
Published in European journal of cancer (1990) (01-11-2014)Get full text
Journal Article -
3
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
Published in Oncogene (20-03-2014)“…The mammalian target of rapamycin (mTOR) regulates cell growth by integrating nutrient and growth factor signaling and is strongly implicated in cancer. But…”
Get full text
Journal Article -
4
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
Published in Leukemia (01-09-2008)“…The phosphatidylinositol 3-kinase (PI3K)/Akt and mammalian target of rapamycin complex 1 (mTORC1) signaling pathways are frequently activated in acute…”
Get full text
Journal Article -
5
Bio-orthogonal Affinity Purification of Direct Kinase Substrates
Published in Journal of the American Chemical Society (20-04-2005)“…Protein phosphorylation is a major mechanism of post-translational protein modification used to control cellular signaling. A challenge in phosphoproteomics is…”
Get full text
Journal Article -
6
A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src
Published in Bioorganic & medicinal chemistry (01-08-1998)“…Engineered proteins with specificity for unnatural substrates or ligands are useful tools for studying or manipulating complex biological systems. We have…”
Get full text
Journal Article -
7
Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor
Published in Proceedings of the National Academy of Sciences - PNAS (08-03-2005)“…The identification of the kinase or kinases targeted by protein kinase inhibitors is a critical challenge in validating their use as therapeutic agents or…”
Get full text
Journal Article -
8
A new strategy for the generation of catalytic antibodies
Published in Nature (London) (16-03-1989)“…The high binding affinity and specificity of antibodies for a wide range of ligands has recently been exploited in the generation of catalysts for…”
Get full text
Journal Article